These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 39138647)

  • 1. Pembrolizumab plus cetuximab with neoadjuvant chemotherapy for head and neck squamous cell carcinoma.
    Yao Z; Wang J; Jiang Y; Zhang Y; Liu J; Dai L; Shen S; Zhou X; Liu Q; Zheng L; Qian M; Li J
    Head Neck; 2025 Jan; 47(1):289-299. PubMed ID: 39138647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy with cetuximab or durvalumab for locoregionally advanced head and neck cancer in patients with a contraindication to cisplatin (NRG-HN004): an open-label, multicentre, parallel-group, randomised, phase 2/3 trial.
    Mell LK; Torres-Saavedra PA; Wong SJ; Kish JA; Chang SS; Jordan RC; Liu T; Truong MT; Winquist EW; Takiar V; Wise-Draper T; Robbins JR; Rodriguez CP; Awan MJ; Beadle BM; Henson C; Narayan S; Spencer SA; Powell S; Dunlap N; Sacco AG; Hu KS; Park HS; Bauman JE; Harris J; Yom SS; Le QT
    Lancet Oncol; 2024 Dec; 25(12):1576-1588. PubMed ID: 39551064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
    Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-line pembrolizumab with or without chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up of the Japanese population of KEYNOTE‑048.
    Oridate N; Takahashi S; Tanaka K; Shimizu Y; Fujimoto Y; Matsumoto K; Yokota T; Yamazaki T; Takahashi M; Ueda T; Hanai N; Yamaguchi H; Hara H; Yoshizaki T; Yasumatsu R; Nakayama M; Shiga K; Fujii T; Mitsugi K; Takahashi K; Nohata N; Gumuscu B; Lerman N; Tahara M
    Int J Clin Oncol; 2024 Dec; 29(12):1825-1839. PubMed ID: 39382718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic body radiotherapy with sequential tislelizumab and chemotherapy as neoadjuvant therapy in patients with resectable non-small-cell lung cancer in China (SACTION01): a single-arm, single-centre, phase 2 trial.
    Zhao ZR; Liu SL; Zhou T; Chen G; Long H; Su XD; Zhang X; Fu JH; Lin P; Zhang LJ; Rong TH; Wu JD; Li ZC; Su HL; Chen JY; Yang YP; Lin YB; Xi M; Yang H
    Lancet Respir Med; 2024 Dec; 12(12):988-996. PubMed ID: 39305910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
    Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF
    Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reirradiation in head and neck squamous cell carcinoma; prognostic indicators, oncologic and functional outcomes.
    Slater NN; Farsi S; Rogers AL; Herberger L; Penagaricano J; McKee S; King D; Samanta S; Sunde J; Vural E; Moreno MA
    Am J Otolaryngol; 2024; 45(6):104482. PubMed ID: 39116720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety outcomes of pembrolizumab with platinum agent chemotherapy combined with 5-fluorouracil or taxane derivative in head and neck cancer.
    Lee B; Chehab SS; Fan W; Schell MJ; Kirtane KS; Shah AB
    J Oncol Pharm Pract; 2024 Dec; 30(8):1397-1402. PubMed ID: 38043938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L
    Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a randomised, single-centre, double-blind, placebo-controlled, phase 2 trial.
    Liu SL; Li XY; Yang JH; Wen DX; Guo SS; Liu LT; Li YF; Luo MJ; Xie SY; Liang YJ; Sun XS; Yang ZC; Lv XF; Luo DH; Li JB; Liu Q; Wang P; Guo L; Mo HY; Sun R; Yang Q; Lan KQ; Jia GD; Li R; Zhao C; Xu RH; Chen QY; Tang LQ; Mai HQ
    Lancet Oncol; 2024 Dec; 25(12):1563-1575. PubMed ID: 39522541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of efficacy and safety of PD-1/PD-L1 combination therapy in first-line treatment of advanced NSCLC: an updated systematic review and network meta-analysis.
    Yang Y; Chen W; Dong L; Duan L; Gao P
    Clin Transl Oncol; 2024 Oct; 26(10):2488-2502. PubMed ID: 38625495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of efficacy and safety of neoadjuvant immunochemotherapy in young and elderly patients with IIA-IIIB non-small-cell lung cancer in real-world practice.
    Liu J; Huang X; Yang Y; Lv W; Wang Y; Xia P; Hu J
    BMC Pulm Med; 2024 Nov; 24(1):592. PubMed ID: 39614293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Objective responses to first-line neoadjuvant carboplatin-paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial.
    Morgan RD; McNeish IA; Cook AD; James EC; Lord R; Dark G; Glasspool RM; Krell J; Parkinson C; Poole CJ; Hall M; Gallardo-Rincón D; Lockley M; Essapen S; Summers J; Anand A; Zachariah A; Williams S; Jones R; Scatchard K; Walther A; Kim JW; Sundar S; Jayson GC; Ledermann JA; Clamp AR
    Lancet Oncol; 2021 Feb; 22(2):277-288. PubMed ID: 33357510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering the impact of STAT3 activation mediated by PTPRT promoter hypermethylation as biomarker of response to paclitaxel-plus-cetuximab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
    Cirauqui BC; Peguera AB; Pi-Sunyer AQ; Ferrando-Díez A; Serrano JLR; Viñolas MD; García IT; García VQ; Oukadour IC; Valencia AG; Vergara PH; de Aguirre Egaña I; Herrero CQ; Carbonell OM; Paradís AL; Esteve A; Vila MM; Rosell R; Martínez-Cardús A; Mesía R
    Head Neck; 2025 Jan; 47(1):57-67. PubMed ID: 39072941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to induction chemotherapy as a prognostic indicator in locally advanced head and neck squamous cell carcinoma.
    Huwyler F; Giger R; Bill R; Rauch D; Haefliger S
    J Cancer Res Clin Oncol; 2024 Dec; 151(1):2. PubMed ID: 39627558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosimilar monoclonal antibodies for cancer treatment in adults.
    Galvao TF; Livinalli A; Lopes LC; Zimmermann IR; Silva MT
    Cochrane Database Syst Rev; 2024 Nov; 11(11):CD013539. PubMed ID: 39607013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bortezomib in multiple myeloma and lymphoma: a systematic review and clinical practice guideline.
    Reece D; Imrie K; Stevens A; Smith CA;
    Curr Oncol; 2006 Oct; 13(5):160-72. PubMed ID: 22792013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial.
    Rha SY; Oh DY; Yañez P; Bai Y; Ryu MH; Lee J; Rivera F; Alves GV; Garrido M; Shiu KK; Fernández MG; Li J; Lowery MA; Çil T; Cruz FM; Qin S; Luo S; Pan H; Wainberg ZA; Yin L; Bordia S; Bhagia P; Wyrwicz LS;
    Lancet Oncol; 2023 Nov; 24(11):1181-1195. PubMed ID: 37875143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What Are the Functional, Radiographic, and Survivorship Outcomes of a Modified Cup-cage Technique for Pelvic Discontinuity?
    Mu W; Xu B; Wahafu T; Wang F; Guo W; Zou C; Cao L
    Clin Orthop Relat Res; 2024 Dec; 482(12):2149-2160. PubMed ID: 38991223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.